Kyverna Therapeutics, Inc. (KYTX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Kyverna Therapeutics, Inc. (KYTX) Company Statistics | The Fly

Kyverna Therapeutics, Inc.

· KYTX

Dashboard

Financials

Ratios

Valuation

Statistics

423.009 M

-0.58%

General

Market Cap: $423.01M
Enterprise Value: $414.6M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -69.44%
ROE: -81.91%
ROIC: -80.05%
Current Ratio: 9.06
Debt-to-Equity: 0.20
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 2.50
EV/EBITDA: -2.78

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $158.58M
Operating Income: -$158.93M
Net Profit: -$152.64M

Balance Sheet

Cash and Equivalents: $31.81M
Working Capital: $183.74M
Total Assets: $219.82M
Net Debt: $1.19M
Total Liabilities: $54.27M
Total Equity: $165.55M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$158.75M
Cash Flow from Investing: -$8.8M
Cash Flow from Financing: $145.92M
Free Cash Flow: -$159.43M
Capital Expenditures: $680K